StockDuty ← Dashboard Sep 16, 2026 04:07 PM ET
CatalystCorporate

HALEON TAKES ADVANTAGE OF GLP-1 SIDE EFFECTS AS US SALES RISE - SEEKINGALPHA

Haleon capitalizes on GLP-1 side effects, driving US sales growth.

Haleon capitalizes on GLP-1 side effects, driving US sales growth.
Haleon capitalizes on GLP-1 side effects, driving US sales growth. — impact context not separately stored; see What changed.
Sources